FuZhengHuaYuJiangZhuTongLuoFang Prescription Modulates Gut Microbiota and Gut-Derived Metabolites in UUO Rats
ConclusionOur study revealed that FZHY reduced kidney damage at the early stage of CKD by regulating the above four candidate bacteria biomarkers and gut-derived harmful metabolites, inhibiting the inflammation response and tubulointerstitial fibrosis, providing deep insight into CKD therapeutic strategy.
Source: Frontiers in cellular and infection microbiology - Category: Microbiology Source Type: research
More News: Bilirubin | China Health | Chronic Kidney Disease | Herbs | Microbiology | Sodium | Sodium Chloride | Study | Ureter and Renal Pelvis Cancer | Urology & Nephrology